Adlai Nortye FY2026 EPS Estimate Raised by HC Wainwright

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) – Research analysts at HC Wainwright raised their FY2026 earnings per share (EPS) estimates for shares of Adlai Nortye in a report issued on Friday, August 14th. HC Wainwright analyst J. Pantginis now expects that the company will earn ($0.17) per share for the year, up from their previous forecast of ($0.23). HC Wainwright currently has a “Buy” rating and a $20.00 target price on the stock. The consensus estimate for Adlai Nortye’s current full-year earnings is ($0.32) per share. HC Wainwright also issued estimates for Adlai Nortye’s FY2027 earnings at ($0.16) EPS and FY2028 earnings at ($0.19) EPS.

ANL has been the subject of several other research reports. JonesTrading started coverage on Adlai Nortye in a report on Thursday, May 14th. They set a “buy” rating and a $22.00 price target for the company. Cantor Fitzgerald initiated coverage on Adlai Nortye in a research note on Monday, June 22nd. They issued an “overweight” rating on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Adlai Nortye in a research report on Tuesday, July 14th. Finally, Oppenheimer assumed coverage on Adlai Nortye in a research note on Thursday, May 28th. They set an “outperform” rating and a $32.00 price objective for the company. Five equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Adlai Nortye presently has an average rating of “Moderate Buy” and an average price target of $24.25.

Adlai Nortye Stock Up 0.7%

Shares of Adlai Nortye stock opened at $13.34 on Tuesday. The stock’s fifty day moving average is $11.50 and its 200 day moving average is $10.88. Adlai Nortye has a one year low of $0.88 and a one year high of $17.25.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. SmartHarvest Portfolios LLC boosted its holdings in Adlai Nortye by 8.5% in the 1st quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock worth $113,000 after buying an additional 1,279 shares during the period. Renaissance Technologies LLC bought a new stake in Adlai Nortye during the first quarter valued at about $457,000. Affinity Asset Advisors LLC bought a new stake in Adlai Nortye during the first quarter valued at about $1,140,000. ADAR1 Capital Management LLC purchased a new position in shares of Adlai Nortye in the first quarter valued at about $816,000. Finally, Boone Capital Management LLC purchased a new position in shares of Adlai Nortye in the second quarter valued at about $2,971,000. Hedge funds and other institutional investors own 35.21% of the company’s stock.

About Adlai Nortye

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.